tiprankstipranks
Advertisement
Advertisement
PROCEPT BioRobotics: Neutral/Hold Rating Reflects Weaker Procedure Growth Outlook and Delayed Profitability Despite Solid Revenue and International Expansion
PremiumRatingsPROCEPT BioRobotics: Neutral/Hold Rating Reflects Weaker Procedure Growth Outlook and Delayed Profitability Despite Solid Revenue and International Expansion
1M ago
Procept BioRobotics price target lowered to $20 from $24 at Baird
Premium
The Fly
Procept BioRobotics price target lowered to $20 from $24 at Baird
1M ago
Procept BioRobotics price target lowered to $25 from $35 at Piper Sandler
Premium
The Fly
Procept BioRobotics price target lowered to $25 from $35 at Piper Sandler
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100